Vaulx-Milieu, France

Hervé Dumas



Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hervé Dumas: Innovator in Pharmaceutical Chemistry

Introduction

Hervé Dumas is a notable inventor based in Vaulx-Milieu, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 4 patents to his name, Dumas has focused on addressing critical health issues through his research.

Latest Patents

Dumas's latest patents revolve around butenoic acid derivatives. These compounds are designed for the treatment of dyslipidaemia, atherosclerosis, and diabetes. The inventions include processes for the preparation of these derivatives and pharmaceutical compositions that incorporate them. The specific formulae and processes are detailed in his patents, showcasing his commitment to advancing medical science.

Career Highlights

Hervé Dumas is currently associated with Merck Patent GmbH, where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in developing new therapeutic options that can improve patient outcomes. Dumas's expertise in chemical processes and pharmaceutical formulations has established him as a key figure in his field.

Collaborations

Throughout his career, Dumas has collaborated with esteemed colleagues such as Francois Collonges and Peter Kane. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Hervé Dumas exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions through patents and collaborations highlight his dedication to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…